National Institute for Cellular Biotechnology, Dublin City University, Glasnevin, Dublin 9, Ireland.
Department of Clinical Microbiology, Royal College of Surgeons in Ireland, Education and Research Centre, Beaumont Hospital, Beaumont Road, Dublin 9, Ireland.
Biotechnol J. 2018 Mar;13(3):e1700299. doi: 10.1002/biot.201700299. Epub 2017 Oct 30.
Genetic engineering of mammalian cells is of interest as a means to boost bio-therapeutic protein yield. X-linked inhibitor of apoptosis (XIAP) overexpression has previously been shown to enhance CHO cell growth and prolong culture longevity while additionally boosting productivity. The authors confirmed this across a range of recombinant products (SEAP, EPO, and IgG). However, stable overexpression of an engineering transgene competes for the cells translational machinery potentially compromising product titre. MicroRNAs are attractive genetic engineering candidates given their non-coding nature and ability to regulate multiple genes simultaneously, thereby relieving the translational burden associated with stable overexpression of a protein-encoding gene. The large number of potential targets of a single miRNA, falsely predicted in silico, presents difficulties in identifying those that could be useful engineering tools. The authors explored the identification of direct miRNA regulators of the pro-survival endogenous XIAP gene in CHO-K1 cells by using a miR-CATCH protocol. A biotin-tagged antisense DNA oligonucleotide for XIAP mRNA is designed and used to pull down and capture bound miRNAs. Two miRNAs are chosen out of the 14 miRNAs identified for further validation, miR-124-3p and miR-19b-3p. Transient transfection of mimics for both results in the diminished translation of endogenous CHO XIAP protein whereas their inhibition increases XIAP protein levels. A 3'UTR reporter assay confirms miR-124-3p to be a bona fide regulator of XIAP in CHO-K1 cells. This method demonstrates a useful approach to finding miRNA candidates for CHO cell engineering without competing for the cellular translational machinery.
哺乳动物细胞的基因工程作为提高生物治疗蛋白产量的一种手段很有意义。先前的研究表明,凋亡抑制因子(XIAP)的过表达可以增强 CHO 细胞的生长和延长培养寿命,同时还可以提高生产力。作者在一系列重组产品(SEAP、EPO 和 IgG)中证实了这一点。然而,工程转基因的稳定过表达会与细胞的翻译机制竞争,可能会降低产品的产量。由于非编码性质和同时调节多个基因的能力,microRNAs 是有吸引力的基因工程候选物,从而减轻与稳定过表达蛋白质编码基因相关的翻译负担。单个 miRNA 的大量潜在靶点,在计算机上被错误地预测,这在确定那些可能成为有用的工程工具的靶点方面存在困难。作者通过使用 miR-CATCH 方案,探索了鉴定 CHO-K1 细胞中促生存内源性 XIAP 基因的直接 microRNA 调节剂。设计并使用针对 XIAP mRNA 的生物素标记反义 DNA 寡核苷酸来下拉和捕获结合的 microRNAs。从鉴定出的 14 个 microRNAs 中选择出两个 microRNAs 进行进一步验证,即 miR-124-3p 和 miR-19b-3p。瞬时转染这两种 microRNA 的模拟物都会导致内源性 CHO XIAP 蛋白的翻译减少,而它们的抑制会增加 XIAP 蛋白水平。3'UTR 报告基因测定证实 miR-124-3p 是 CHO-K1 细胞中 XIAP 的真正调节因子。该方法证明了一种有用的方法,可以在不与细胞翻译机制竞争的情况下,为 CHO 细胞工程寻找 microRNA 候选物。